ABSTRACT: Cytochrome P450 (CYP) 1A1 is the most important enzyme activating and detoxifying the human carcinogen benzo[a]pyrene (BaP). In the previous studies, we had shown that not only the canonic NADPH:CYP oxidoreductase (POR) can act as electron donor but also cytochrome b5 and its reductase, NADH:cytochrome b5 reductase. Here, we studied the role of the expression system used on the metabolites generated and the levels of DNA adducts formed by activated BaP. We used an eukaryotic and a prokaryotic cellular system (Supersomes, microsomes isolated from insect cells, and Bactosomes, a membrane fraction of Escherichia coli, each transfected with cDNA of human CYP1A1 and POR). These were reconstituted with cytochrome b5 with and without NADH:cytochrome b5 reductase. We evaluated the effectiveness of each cofactor, NADPH and NADH, to mediate BaP metabolism. We found that both systems differ in catalysing the reactions activating and detoxifying BaP. Two BaP-derived DNA adducts were generated by the CYP1A1-Supersomes, both in the presence of NADPH and NADH, whereas NADPH but not NADH was able to support this reaction in the CYP1A1-Bactosomes. Seven BaP metabolites were found in Supersomes with NADPH or NADH, whereas NADPH but not NADH was able to generate five BaP metabolites in Bactosomes. Our study demonstrates different catalytic efficiencies of CYP1A1 expressed in prokaryotic and eukaryotic cells in BaP bioactivation indicating some limitations in the use of E. coli cells for such studies.

Analytical and Environmental Sciences Division MRC PHE Centre for Environment and Health King's College London London SE1 9NH UK

Department of Biochemistry Faculty of Science Charles University Albertov 2030 128 40 Prague 2 Czech Republic

Division of Radiopharmaceutical Chemistry German Cancer Research Center Im Neuenheimer Feld 280 69120 Heidelberg Germany

NIHR Health Protection Research Unit in Health Impact of Environmental Hazards at King's College London in Partnership with Public Health England London SE1 9NH UK

See more in PubMed

International Agency for Research on Cancer, (IARC) Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr Eval Carcinog Risks Hum. 2010;92:1. PubMed PMC

Kucab JE, van Steeg H, Luijten M, Schmeiser HH, White PA, Phillips DH, Arlt VM. Mutat Res. 2015;773:48. doi: 10.1016/j.mrfmmm.2015.01.013. PubMed DOI PMC

Baird WM, Hooven LA, Mahadevan B. Environ Mol Mutagen. 2005;45:106. doi: 10.1002/em.20095. PubMed DOI

Stiborová M, Indra R, Moserová M, Frei E, Schmeiser HH, Kopka K, Phillips DH, Arlt VM. Chem Res Toxicol. 2016;29:1325. doi: 10.1021/acs.chemrestox.6b00143. PubMed DOI PMC

Stiborová M, Indra R, Moserová M, Šulc M, Hodek P, Frei E, Schmeiser HH, Arlt VM. Monatsh Chem. 2016;147:847. doi: 10.1007/s00706-016-1713-y. PubMed DOI PMC

Wohak LE, Krais AM, Kucab JE, Stertmann J, Øvrebø S, Seidel A, Phillips DH, Arlt VM. Arch Toxicol. 2016;90:291. doi: 10.1007/s00204-014-1409-1. PubMed DOI PMC

Sims P, Grover PL, Swaisland A, Pal K, Hewer A. Nature. 1974;252:326. doi: 10.1038/252326a0. PubMed DOI

Wood AW, Levin W, Lu AY, Yagi H, Hernandez O, Jerina DM, Conney AH. J Biol Chem. 1976;251:4882. PubMed

Bauer E, Guo Z, Ueng YF, Bell LC, Zeldin D, Guengerich FP. Chem Res Toxicol. 1995;8:136. doi: 10.1021/tx00043a018. PubMed DOI

Arlt VM, Stiborova M, Henderson CJ, Thiemann M, Frei E, Aimova D, Singhs R, da Costa GG, Schmitz OJ, Farmer PB, Wolf CR, Philips DH. Carcinogenesis. 2008;29:656. doi: 10.1093/carcin/bgn002. PubMed DOI

Arlt VM, Poirier MC, Sykes SE, Kaarthik J, Moserova M, Stiborova M, Wolf R, Henderson CJ, Phillips DH. Toxicol Lett. 2012;213:160. doi: 10.1016/j.toxlet.2012.06.016. PubMed DOI PMC

Walsh AA, Szklarz GD, Scott EE. J Biol Chem. 2013;288:12932. doi: 10.1074/jbc.M113.452953. PubMed DOI PMC

Chun YJ, Shimada T, Guengerich FP. Arch Biochem Biophys. 1996;330:48. doi: 10.1006/abbi.1996.0224. PubMed DOI

Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR. Carcinogenesis. 1998;19:1847. doi: 10.1093/carcin/19.10.1847. PubMed DOI

Jiang H, Gelhaus SL, Mangal D, Harvey RG, Blair IA, Penning TM. Chem Res Toxicol. 2007;20:1331. doi: 10.1021/tx700107z. PubMed DOI PMC

Zhu S, Li L, Thornton C, Carvalho P, Avery BA, Willett KL. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;863:141. doi: 10.1016/j.jchromb.2008.01.018. PubMed DOI PMC

King HW, Thompson MH, Brookes P. Int J Cancer. 1976;18:339. doi: 10.1002/ijc.2910180311. PubMed DOI

Fang AH, Smith WA, Vouros P, Gupta RC. Biochem Biophys Res Commun. 2001;281:383. doi: 10.1006/bbrc.2000.4161. PubMed DOI

Stiborova M, Moserova M, Cerna V, Indra R, Dracinsky M, Šulc M, Henderson CJ, Wolf CR, Schmeiser HH, Phillips DH, Frei E, Arlt VM. Toxicology. 2014;318:1. doi: 10.1016/j.tox.2014.02.002. PubMed DOI

Šulc M, Indra R, Moserová M, Schmeiser HH, Frei E, Arlt VM, Stiborová M. Environ Mol Mutagen. 2016;57:229. doi: 10.1002/em.22001. PubMed DOI PMC

Lu AY, West SB, Vore M, Ryan D, Levin W. J Biol Chem. 1974;249:6701. PubMed

West SB, Levin W, Ryan D, Vore M, Lu AY. Biochem Biophys Res Commun. 1974;58:516. doi: 10.1016/0006-291X(74)90395-7. PubMed DOI

Gautier JC, Urban P, Beaune P, Pompon D. Eur J Biochem. 1993;211:63. doi: 10.1111/j.1432-1033.1993.tb19870.x. PubMed DOI

Gautier JC, Lecoeur S, Cosme J, Perret A, Urban P, Beaune P, Pompon D. Pharmacogenetics. 1996;6:489. doi: 10.1097/00008571-199612000-00002. PubMed DOI

Shimada T, Gillam EM, Oda Y, Tsumura F, Sutter TR, Guengerich FP, Inoue K. Chem Res Toxicol. 1999;12:623. doi: 10.1021/tx990028s. PubMed DOI

Schwarz D, Kisselev P, Cascorbi I, Schunck WH, Roots I. Carcinogenesis. 2001;22:453. doi: 10.1093/carcin/22.3.453. PubMed DOI

Shiizaki K, Kawanishi M, Yagi T. Mutat Res. 2013;750:77. doi: 10.1016/j.mrgentox.2012.09.008. PubMed DOI

Indra R, Moserova M, Sulc M, Frei E, Stiborova M. Neuro Endocrinol Lett. 2013;34(Suppl 2):55. PubMed

Indra R, Moserova M, Kroftova N, Sulc M, Martinkova M, Adam V, Eckschlager T, Kizek R, Arlt VM, Stiborova M. Neuro Endocrinol Lett. 2014;35(Suppl 2):105. PubMed

Divi RL, Lindeman TL, Shockley ME, Keshava C, Weston A, Poirier MC. Mutagenesis. 2014;29:409. doi: 10.1093/mutage/geu049. PubMed DOI PMC

Guengerich FP. Chem Res Toxicol. 2008;21:70. doi: 10.1021/tx700079z. PubMed DOI

Porter TD. J Biochem Mol Toxicol. 2002;16:311. doi: 10.1002/jbt.10052. PubMed DOI

Schenkman JB, Jansson I. Pharmacol Ther. 2003;97:139. doi: 10.1016/S0163-7258(02)00327-3. PubMed DOI

McLaughin LA, Ronseaux S, Finn RD, Henderson CJ, Wolf CR. Mol Pharmacol. 2010;75:269. doi: 10.1124/mol.110.064246. PubMed DOI

Kotrbova V, Mrazova B, Moserova M, Martinek V, Hodek P, Hudecek J, Frei E, Stiborova M. Biochem Pharmacol. 2011;82:669. doi: 10.1016/j.bcp.2011.06.003. PubMed DOI

Stiborova M, Indra R, Moserova M, Cerna V, Rupertova M, Martinek V, Eckschlager T, Kizek R, Frei E. Chem Res Toxicol. 2012;25:1075. doi: 10.1021/tx3000335. PubMed DOI

Anzenbacher P, Anzenbacherová E. Cell Mol Life Sci. 2001;58:737. doi: 10.1007/PL00000897. PubMed DOI PMC

Guengerich FP, Parikh A. Curr Opin Biotechnol. 1997;8:623. doi: 10.1016/S0958-1669(97)80039-0. PubMed DOI

Kramer MA, Tracy TS. Expert Opin Drug Metab Toxicol. 2008;4:591. doi: 10.1517/17425255.4.5.591. PubMed DOI

Guguen-Guillouzo C, Guillouzo A. Methods Mol Biol. 2010;640:1. doi: 10.1007/978-1-60761-688-7_1. PubMed DOI

Davydov DR. Expert Opin Drug Metab Toxicol. 2011;7:543. doi: 10.1517/17425255.2011.562194. PubMed DOI PMC

Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Ong CE. Protein J. 2011;30:581. doi: 10.1007/s10930-011-9365-6. PubMed DOI

Pan Y, Mak JW, Ong CE. Biomed Chromatogr. 2013;27:859. doi: 10.1002/bmc.2872. PubMed DOI

Faiq MA, Ali M, Dada T, Dada R, Saluja D. PLoS One. 2014;9:e110473. doi: 10.1371/journal.pone.0110473. PubMed DOI PMC

Quehl P, Hollender J, Schüürmann J, Brossette T, Maas R, Jose J. Microb Cell Fact. 2016;15:26. doi: 10.1186/s12934-016-0427-5. PubMed DOI PMC

Schneiter R, Toulmay A. Appl Microbiol Biotechnol. 2007;73:1224. doi: 10.1007/s00253-006-0707-9. PubMed DOI

Krais AM, Speksnijder EN, Melis JP, Indra R, Moserova M, Godschalk RW, van Schooten FJ, Seidel A, Kopka K, Schmeiser HH, Stiborova M, Phillips DH, Luijten M, Arlt VM. Arch Toxicol. 2016;90:291. doi: 10.1007/s00204-015-1531-8. PubMed DOI PMC

Stiborová M, Martínek V, Svobodová M, Sístková J, Dvorák Z, Ulrichová J, Simánek V, Frei E, Schmeiser HH, Phillips DH, Arlt VM. Chem Res Toxicol. 2010;23:1192. doi: 10.1021/tx100052d. PubMed DOI

Stiborova M, Martinek V, Rydlova H, Hodek P, Frei E. Cancer Res. 2002;62:5678. PubMed

Stiborová M, Martínek V, Rýdlová H, Koblas T, Hodek P. Cancer Lett. 2005;220:145. doi: 10.1016/j.canlet.2004.07.036. PubMed DOI

Perkins DM, Duncan JR. J Chromatogr. 1987;405:319. doi: 10.1016/S0021-9673(01)81773-8. PubMed DOI

Ross PH. J Chromatogr B. 1996;684:107. doi: 10.1016/0378-4347(96)00018-7. PubMed DOI

Hodek P, Koblihova J, Kizek R, Frei E, Arlt VM, Stiborova M. Environ Toxicol Pharmacol. 2013;36:989. doi: 10.1016/j.etap.2013.09.004. PubMed DOI

Schmeiser HH, Stiborova M, Arlt VM. Methods Mol Biol. 2013;1044:389. doi: 10.1007/978-1-62703-529-3_21. PubMed DOI

Benzo[a]pyrene-Induced Genotoxicity in Rats Is Affected by Co-Exposure to Sudan I by Altering the Expression of Biotransformation Enzymes